|

[225Ac]Ac-AKY-1189 (therapeutic) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Aktis Oncology, Inc.1

Indications

  • Cervical Adenocarcinoma1
  • Urothelial Carcinoma Bladder1
  • Colorectal Adenocarcinoma1
  • Hormone Receptor Positive Breast Adenocarcinoma1
  • Triple Negative Breast Cancer (TNBC)1

Duarte, California1 trial

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.